期刊文献+

连续贴壁法分离培养人外周血来源树突状细胞及其超微结构的观察 被引量:4

Culturing dendritic cells from the peripheral blood with successive adherence method and observing the utralmicrostructure of cells
下载PDF
导出
摘要 目的改进人外周血单个核细胞分离培养树突状细胞的方法,电镜观察树突状细胞超微结构。方法利用连续贴壁法分离获得CD14+前体细胞,经人重组粒细胞/巨噬细胞集落刺激因子(rhGM-CSF)、白介素-4(rhIL-4)和肿瘤坏死因子α(TNF-α)诱导产生成熟DC,流式细胞仪检测DC表面标志物表达水平,透射电镜(TEM)观察树突状细胞超微结构。结果连续贴壁法体外分离培养人外周血DC,所获得DC数量和纯度均都多于以往一次贴壁分离培养的DC。培养1周的DC高表达CD1a、CD40、HLA-DR、CD80、CD86。透射电镜观察到不同状态树突状细胞的超微结构。结论连续贴壁法可分离培养数量较大、纯度较高的人外周血来源DC。 Objective: To improve the method of isolated cultivation of dendritic cells (DC) from the peripheral blood and observe the utralmicrostructure of dendritic cells with electron microscope, Methods: Utilizing successive adherence method to obtain CD14^+ precursor cells, The mature DC was induced in vitro by granuloeyte - macrophage colony - stimulating factor ( GM - CSF), interleukin - 4 ( IL - 4 ) and tumor necrosis factor - α ( TNF - α ). Detecting the expression level of DC surface markers by flow cytometry. Observing the utralmicro structure of dendritic cells with transmission electron microscope (TEM). Results: A large number of of DC with higher purity that were isolated from human peripheral blood in successive adherence method were obtained compare with one time - adhenrence method. The DC cultured one week highly expressed CD1 a, CD40, HLA - DR, CD83 and CD86. We observed the utralmicrostructure of dendritic cells in different state with transmission' electron microscope ( TEM ). Conclusion: We can get comparatively large number of DC with high purity in successive adherence method.
出处 《现代肿瘤医学》 CAS 2007年第3期301-304,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(30400167)
关键词 连续贴壁法 树突状细胞 透射电镜 successive adherence method dendritic cells transmission electron microscope
  • 相关文献

参考文献7

  • 1Banchereau J,Steinman RM.Dendritic cells and the control of immunity[J].Nature,1998,392:245~250.
  • 2Nishioka Y,Hua W,Nishimura N,et al.Genetic modificaton of dendritic cens and its application for cancer immunotherapy[J].J Med Invest,2002,49(1/2):1~17.
  • 3lnaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J].J Exp Med,1992,176(6):1693~1702.
  • 4Sallusto F,Lanzavecchia A.Eficient presentation of soluble antigen by cuhured human dendritic cells is maintianed by granulocyte/macmphage colony-stimulating factor plus interleukin-4 and down regulated by tumor necrosis factor[J].J Exp Med,1994,179(4):1109~1117.
  • 5Koido S,Hara E,Homma S,et al.Dendritic ceils fused with allogeneic coloreetal cancer cell line present multiple eoloreetal cancer -specific antigens and induce antitumor immunity against autologous tumor cells[J].Clin Cancer Res,2005,11(21):7891~7900.
  • 6张红梅,张利旺,贾军,任军.肿瘤患者自体血浆诱导树突状细胞的实验研究[J].现代肿瘤医学,2005,13(6):740-743. 被引量:2
  • 7张利旺,张红梅,贾军,任军.以AFP为靶点的肝癌树突状细胞免疫治疗的实验研究[J].现代肿瘤医学,2005,13(6):736-739. 被引量:9

二级参考文献15

  • 1Caux C, Dubois B. Propagation of human dendritic cells in vitro[A]. Robinson SP, Stagg AJ. methods in molecular Medicine [M]. Vol 64. Totowa: Human Press Inc,2000, 257~273.
  • 2Markowicz S, Engleman EG. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro[J]. Clin Invest, 1990 ,85:955~961.
  • 3Cherylyn AS, Monica LG, Bohuslav M, et al. Multidimensional flow- cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients[J]. Cancer Immunol Immunother, 1998, 45:234~240.
  • 4Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability[J]. Immunol Methods, 1996, 196:137~151.
  • 5Herbst B,Kohler G,Mackensen A,et a1.CD34 peripheral blood progenitor cell and monocyte derived dendritic cells:a comparative analysis[J].Br J Haematol,1997,99(3):490.
  • 6Duperrier K, Eljaafari A, Dezutter-Dambuyant C, et al. Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements[J]. Immunol Methods,2000, 238(1-2):119~131.
  • 7Bronte V, Apolloni E, Ronca R, et al. Genetic vaccination with "self' tyrosinase-related protein 2 causes melanoma eradication but not vitiligo[J]. Cancer Research, 2000, 60:253~258.
  • 8Tuting V, Gambotto A, DeLeo A, et al. Induction of tumor antigen specific immunity using plasmid DNA immunization in mice[J]. Cancer Gene Therapy, 1999, 6:73~80.
  • 9Conry RM, LoBuglio AF, Loechel F, et al. A carcinoembryonic antigen polynucleotide vaccine for human clinical use[J]. Cancer Gene Therapy, 1995, 2:33~38.
  • 10Petra Hanke, Matthias Serwe, Frank Dombrowski, et al. DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice[J]. Cancer Gene Therapy, 2002,9:346~355.

共引文献9

同被引文献27

  • 1张玮玮.流式细胞术的发展、原理及临床应用[J].当代医学,2008,14(3):23-24. 被引量:9
  • 2徐勇,霍梅.免疫磁珠分离及流式细胞仪分选纯化外周血CD34^+/CD90^+干细胞[J].临床检验杂志,2004,22(4):246-248. 被引量:15
  • 3Robert WC,Craig A,Benjamin O,et al.NCCN Practice Guidelines in Oncology:Breast Cancer[J].Natl Compr Canc Netw,2008(Suppl):79-82.
  • 4Gabizon A,Martin F.Polyethylene Glycol-coated(pegylated) liposomal doxorubicin:rationale for use in solid tumours[J].Drugs,1997,54(suppl 4):15-21.
  • 5Singal PK,Iliskovic N.Doxorubicin-induced cardiomyopathy[J].N Engl J Med,1998,339:900-905.
  • 6Sreter I,Kiss A,Cornides A,et al.Inhibition of doxorubicin induced liver toxicity by a new dihydroquinoline type antioxidant[J].Acta Physiologica Hungarica,1984,64:431-435.
  • 7Girl SN,Al-Bayati MA,Du X,et al.Amelioration of doxorubicin-induced cardiac and renal toxicity by piffenidone in rats[J].Cancer Chemother Pharmacol,2004,53:141-150.
  • 8Swenson CE,Bolcsak LE,Batist G,et al.Pharmacokinetics of doxorubicin administered i.v.as Myocet (TIC D-99;liposomeencapsulated doxorubicin citrate) compared with conventional doxonthicin when given in combination with cyclophesphamide in patients with metastatic breast cancer[J].Anticancer Drugs,2003,14:239-246.
  • 9Bao A.Goins B,Klipper R,et al.Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies[J].J Pharmacol Exp Ther,2004,308:419-452.
  • 10Thompson EW,Paik S,Brunner N,et al.Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines[J].J Cell Physiol,1992,150:534-544.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部